E. Krzywinska, N. Allende-vega, A. Cornillon, D. Vo, L. Cayrefourcq et al., Identification of anti tumor cells carrying natural killer (NK) cell antigens in patients with hematological cancers, EBioMedicine, vol.2, pp.1364-76, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01867114

R. Kaplan, B. Morse, K. Huebner, C. Croce, R. Howk et al., Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain, Proc Natl Acad Sci U S A, vol.87, issue.18, p.54670, 1990.

I. Rhee and A. Veillette, Protein tyrosine phosphatases in lymphocyte activation and autoimmunity, Nat Immunol, vol.13, issue.5, pp.439-486, 2012.
DOI : 10.1038/ni.2246

K. Kishihara, J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai et al., Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice, Cell, vol.74, issue.1, p.8334701, 1993.
DOI : 10.1016/0092-8674(93)90302-7

K. F. Byth, L. A. Conroy, S. Howlett, A. J. Smith, J. May et al., CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation, J Exp Med, vol.183, issue.4, p.2192485, 1996.

P. J. Mee, M. Turner, M. A. Basson, P. S. Costello, R. Zamoyska et al., Greatly reduced efficiency of both positive and negative selection of thymocytes in CD45 tyrosine phosphatase-deficient mice, Eur J Immunol, vol.29, issue.9, p.10508267, 1999.

C. Kung, J. T. Pingel, M. Heikinheimo, T. Klemola, K. Varkila et al., Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease, Nat Med, vol.6, issue.3, pp.343-348, 2000.

E. Z. Tchilian, D. L. Wallace, R. S. Wells, D. R. Flower, G. Morgan et al., A deletion in the gene encoding the CD45 antigen in a patient with SCID, J Immunol, vol.166, issue.2, p.11145714, 2001.

T. Mustelin, T. Vang, and N. Bottini, Protein tyrosine phosphatases and the immune response, Nat Rev Immunol, vol.5, issue.1, pp.43-57, 2005.
DOI : 10.1038/nri1530

N. Allende-vega, E. Krzywinska, S. Orecchioni, N. Lopez-royuela, F. Reggiani et al., The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism, Oncotarget, vol.6, p.26231043, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01835529

M. L. Hermiston, J. Zikherman, J. W. Zhu, C. Cd45, and L. , Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells, Immunol Rev, vol.228, issue.1, p.2739744, 2009.
DOI : 10.1111/j.1600-065x.2008.00752.x

URL : http://europepmc.org/articles/pmc2739744?pdf=render

V. Beziat, B. Descours, C. Parizot, P. Debre, and V. Vieillard, NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs, PLoS One, vol.5, issue.8, p.2917352, 2010.

J. Clausen, B. Vergeiner, M. Enk, A. L. Petzer, G. Gastl et al., Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells, Immunobiology, vol.207, issue.2, pp.85-93, 2003.

K. Juelke, M. Killig, M. Luetke-eversloh, E. Parente, J. Gruen et al., CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells, Blood, vol.116, issue.8, pp.1299-307, 2010.
DOI : 10.1182/blood-2009-11-253286

URL : http://www.bloodjournal.org/content/116/8/1299.full.pdf

S. Lopez-verges, J. M. Milush, S. Pandey, V. A. York, J. Arakawa-hoyt et al., CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset, Blood, vol.116, issue.19, p.2981540, 2010.

K. G. Elpek, M. P. Rubinstein, A. Bellemare-pelletier, A. W. Goldrath, and S. J. Turley, Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes, Proc Natl Acad Sci U S A, vol.107, issue.50, p.3003106, 2010.
DOI : 10.1073/pnas.1012128107

URL : http://www.pnas.org/content/107/50/21647.full.pdf

N. Vey, J. H. Bourhis, N. Boissel, D. Bordessoule, T. Prebet et al., A phase 1 trial of the antiinhibitory KIR mAb IPH2101 for AML in complete remission, Blood, vol.120, issue.22, pp.4317-4340, 2012.

J. Wang and K. Pantopoulos, Regulation of cellular iron metabolism, Biochem J, vol.434, issue.3, p.3048577, 2011.
DOI : 10.1042/bj20101825

URL : http://www.biochemj.org/content/ppbiochemj/434/3/365.full.pdf

B. Grzywacz, N. Kataria, and M. R. Verneris, CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases, Leukemia, vol.21, issue.2, p.17251901, 2007.
DOI : 10.1038/sj.leu.2404499

URL : https://www.nature.com/articles/2404499.pdf

L. Lajoie, C. , N. Bolzec, A. Gouilleux-gruart, V. Sicard et al., ADAM17-mediated shedding of FcgammaRIIIA on human NK cells: identification of the cleavage site and relationship with activation, J Immunol, vol.192, issue.2, pp.741-51, 2014.